By divesting B&L and Salix, Valeant Pharmaceuticals could unlock gains of 300% in VRX stock. Here’s why Valeant stock owners should welcome the deal.
Revlimid sales will remains a catalyst for CELG stock and a big part of Celgene Corporation’s (NASDAQ:CELG) outlook, but there’s more to Celgene stock.
TG Therapeutics Inc (NASDAQ:TGTX) is an AbbVie (NYSE:ABBV) or Johnson & Johnson (NYSE:JNJ) buyout waiting to happen, good news for TGTX stock owners.
Conatus Pharmaceuticals Inc (NASDAQ:CNAT) is a biotechnology company that develops and commercializes new medicines for liver disease.
HQY stock is appealing for a couple of reasons. HealthEquity (NASDAQ:HQY) manages Health Care Savings Accounts or HSAs for thousands of employers.
Also posted in Politics
Tagged HealthEquity, HQY
Valeant Pharmaceuticals (NYSE:VRX) is not Netflix (NASDAQ:NFLX). Bill Ackman’s divestment & VRX stock price suggests an ugly truth for Valeant stock owners.
Revlimid, Otezla, and Ozanimod are three Celgene Corporation (NASDAQ:CELG) drugs that will drive CELG stock higher over the next few years.